Expand your Premium Care
without limits
Dora is a clinical AI agent that calls and supports your cataract patients, helping your practice expand capacity and maintain high standards of care. Dora is live in clinical trials and partnering with select US practices.
Meet Dora, your clinical AI agent.
Intelligent care, delivered at scale.
How Dora works across your cataract pathway
History of Present Illness
Dora calls patients before their first appointment to gather a complete history - in their own words. They arrive prepared, at ease, and ready to engage. You start each consultation with the context you need.
Patient Education
Dora walks patients through their lens options in plain language. No jargon, no pressure. They arrive ready to decide. Every patient gets the same thorough education, freeing your team from repetitive conversations.
Pre-Op Preparation
Days before surgery, Dora calls with clear, step-by-step guidance: what to do, what to avoid, what to expect. Patients show up prepared. Your team fields fewer last-minute calls and manages fewer preventable delays.
Post-Op Care
After surgery, Dora checks in to see how recovery is going and stays available when questions arise at home. Concerns surface early. Real issues get caught sooner while routine recoveries stay out of your schedule.
Testimonials
Dora transforms cataract consultations by obtaining and delivering key patient information in advance, while minimizing bottlenecks throughout the clinic. This empowers surgeons to devote more attention to what matters most: listening, educating, and guiding patients through their options.
Dora doesn't replace clinical judgment; it amplifies it. The result is a more efficient workflow built around a higher standard of patient experience. And because the technology reduces staff time, never misses essential questions, and expands patient access, it positions practices to meet rising demand without compromising quality or outcomes.
Scott LaBorwit, MD
Founder, Select Eye Care
Scott LaBorwit, MD
Founder, Select Eye Care
Dora has been used for over 150,000 consultations in the UK, for referral management, preoperative triage and post surgery follow up. It has significantly increased productivity, efficiency, cost benefit and provided an excellent patient experience and acceptance.
The language used is clinically accurate and aligned with how we expect our teams to communicate. The AI gives us meaningful oversight , essential for both clinical governance, understanding referral management and evaluating the patient experience.
Dr. Paul Rosen
Consultant Ophthalmic Surgeon, Oxford Eye Hospital / Former President, ESCRS
Dr. Paul Rosen
Consultant Ophthalmic Surgeon, Oxford Eye Hospital / Former President, ESCRS
As the first clinical trial site, and after more than two years working closely with Ufonia, I have seen a sustained focus on patient understanding and clinical integrity. Dora has been developed with particular attention to patient education and expectation setting, and as a tool that strengthens the clinical relationship rather than replacing it. That long term, evidence led approach is what makes it compelling.
Dr. Lauren Blieden
Professor of Ophthalmology, Baylor College of Medicine / Principal Investigator, Dora Clinical Trial
Dr. Lauren Blieden
Professor of Ophthalmology, Baylor College of Medicine / Principal Investigator, Dora Clinical Trial
Patient feedback on Dora has been excellent, with CSAT scores consistently above 90%. Patients find the interactions clear and reassuring, which is exactly what matters in patient facing communication. That experience, combined with a trusted and transparent relationship with Ufonia, means the partnership continues to evolve in ways that bring real value to both patients and clinical teams.
Dr. Sarah Maling
Consultant Ophthalmologist / Former Chair of Training for the Royal College of Ophthalmologists
Dr. Sarah Maling
Consultant Ophthalmologist / Former Chair of Training for the Royal College of Ophthalmologists
